Literature DB >> 16178675

Antimicrobial resistance in the hospital setting: impact, trends, and infection control measures.

Gary E Stein1.   

Abstract

The growing threat posed by antibiotic-resistant pathogens is a major challenge for infectious disease practitioners and public health officials. In recent years, the prevalence of resistance among key bacterial pathogens, including Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Streptococcus pneumoniae, and Enterococcus sp, has increased at an alarming rate. The impact of antimicrobial resistance is manifold and can ultimately lead to treatment failure and increased morbidity and mortality. To control the spread of resistance and subsequent impact, a multifaceted approach is warranted. Awareness and surveillance of antimicrobial resistance, prudent use of antibiotics, and compliance with infection control techniques may help contain the emergence and spread of resistant organisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16178675     DOI: 10.1592/phco.2005.25.10part2.44S

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  7 in total

Review 1.  Perioperative strategies to prevent surgical-site infection.

Authors:  Juan Lucas Poggio
Journal:  Clin Colon Rectal Surg       Date:  2013-09

2.  The new epidemiology of nosocomial bacterial infections in cirrhosis: therapeutical implications.

Authors:  Juan Acevedo; Aníbal Silva; Verónica Prado; Javier Fernández
Journal:  Hepatol Int       Date:  2012-08-14       Impact factor: 6.047

3.  Structural evidence suggests that antiactivator ExsD from Pseudomonas aeruginosa is a DNA binding protein.

Authors:  Robert C Bernhards; Xing Jing; Nancy J Vogelaar; Howard Robinson; Florian D Schubot
Journal:  Protein Sci       Date:  2009-03       Impact factor: 6.725

4.  Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study.

Authors:  Tjasa Hranjec; Laura H Rosenberger; Brian Swenson; Rosemarie Metzger; Tanya R Flohr; Amani D Politano; Lin M Riccio; Kimberley A Popovsky; Robert G Sawyer
Journal:  Lancet Infect Dis       Date:  2012-08-28       Impact factor: 25.071

Review 5.  Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination.

Authors:  Mai-Chi Hong; Donald I Hsu; Mark Bounthavong
Journal:  Infect Drug Resist       Date:  2013-11-29       Impact factor: 4.003

6.  Efforts to Prevent Surgical Site Infection After Colorectal Surgery.

Authors:  Byung Wook Min
Journal:  Ann Coloproctol       Date:  2015-12-31

7.  Antibiotic susceptibility of wound swab isolates in a tertiary hospital in Southwest Nigeria.

Authors:  Eguono Erhinyaye Omoyibo; Ayodeji Olarewaju Oladele; Muhammad Habib Ibrahim; Oluwakayode Temitope Adekunle
Journal:  Ann Afr Med       Date:  2018 Jul-Sep
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.